Navigation Links
Repligen in Medical News

Repligen Licenses Patent Rights for Treatment of Bipolar Disorder

...WALTHAM, Mass., March 31 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...rogram of any private, U.S. psychiatric hospital. repligen is developing RG2417, an oral formulation of uridi... Herlihy, President and Chief Executive Officer of repligen Corporation. "Treatment of the symptoms of bipola...

Repligen Announces ISO 9001:2000 Certification

... WALTHAM, Mass., Feb. 12 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ), a global leader in ...lated services underlying its Protein A business. repligen has supplied Protein A products to the biopharmace...ent and Chief Executive Officer of Repligen. repligen is the world's leading supplier of recombinant Pro...

Repligen Reports Second Quarter Fiscal Year 2009 Financial Results

... WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported result... Herlihy, President and Chief Executive Officer of repligen Corporation. "As of September 30th, we had $65 mil...cologic, toxicologic and pharmacodynamic profiles. repligen announced receipt of a $1 million research grant f...

Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder

... WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...d relapse remain common clinical problems. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST

... WALTHAM, Mass., Oct. 30 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... be accessed at http://www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Compound Reverses Huntington's Symptoms in Mice

...published this week in the early edition of the Proceedings of the National Academy of Sciences . The study received funding from Massachusetts-based repligen Corp., which holds several patent applications related to HDAC (histone deacetylase) inhibitors, a class of agents that include HDACi 4b. Other HDA...

Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors

... WALTHAM, Mass., July 1 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "Fred's expertise and relationships w...es and is an inventor on numerous patents. About repligen Corporation ...

Repligen Announces Share Repurchase Program

... WALTHAM, Mass., June 18 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced that ...,000 shares of its common stock. Under the program repligen may repurchase shares from time to time at prevail... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our strong financial position will a...

Repligen Announces Conference Call to Update Orencia(R) Lawsuit

... be accessed at http://www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...lings with the Securities and Exchange Commission. repligen assumes no obligation to update any forward-lookin...

Repligen Elects Earl Henry, M.D. to the Board of Directors

... WALTHAM, Mass., Dec. 13 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "Earl's strategic guidance and relati...rovider of clinical outsourcing solutions. About repligen Corporation ...
Repligen in Medical Technology

Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications

...Schimmel has also been the co-founder or founding director of numerous successful biotechnology companies, including Sirtris Pharmaceuticals, Alnylam, repligen Corporation, Alkermes, Inc., Momenta Pharmaceuticals and Cubist Pharmaceuticals, which were taken public on the NASDAQ and are well established as com...

Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer

...ing drugs to treat inherited and acquired energy impairment diseases. Dr. Rioux' three-decade career includes industry experience at companies such as repligen Corp., Arrow International, Variagenics, Inc., Biogen and GRP (Groupement de Recherche en Pharmacologie). He previously was a researcher in Clinical R...

Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder

... WALTHAM, Mass., June 12 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced that ...ill be the Principal Investigator of this study. repligen previously reported positive initial results from ...d over $200 million in funding since 1989. About repligen Corporation ...

Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging

...WALTHAM, Mass., April 16 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "We expect to complete patient enroll...s year and, if successful, file an NDA in 2009." repligen is currently conducting a Phase 3 clinical trial t...

Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging

...WALTHAM, Mass., March 26 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ... Herlihy, President and Chief Executive Officer of repligen Corporation. "There are approximately 150,000 panc...t could benefit from enhancement with secretin." repligen previously conducted a multi-center, baseline-cont...

Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder

... WALTHAM, Mass., Nov. 8 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today announced posit... Herlihy, President and Chief Executive Officer of repligen Corporation. "The results of this study support fu...ed over $200 million in funding since 1989. About repligen Corporation ...

Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas

... of Orphan Products Development of the FDA granted repligen orphan drug designation for RG1068, synthetic huma...of the pancreas. Orphan drug designation qualifies repligen for seven years of exclusive marketing rights in t...or RG1068 for MRI imaging of the pancreas. About repligen Corporation ...
Repligen in Biological Technology

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

... WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our financial resources will allow ...ge in Bipolar Disorder scale (CGI-BP-C). In March, repligen exclusively licensed worldwide rights to a patent ...

Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results

... WALTHAM, Mass., July 30 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...e accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results

... WALTHAM, Mass., June 11 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Over the next twelve months, we wil...DRS (p=0.01) and the CGI-BP-C (p=0.04). In March, repligen exclusively licensed worldwide rights to a patent ...

Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results

... WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that... be accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the Cowen and Company 29th Annual Healthcare Conference Monday, March 16th, 2:25 p.m. EDT

... WALTHAM, Mass., March 9 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...or 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Reports Third Quarter Fiscal Year 2009 Financial Results

... WALTHAM, Mass., Feb. 5 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) today reported resul... Herlihy, President and Chief Executive Officer of repligen Corporation. "Our financial resources will allow ...s. Stock Repurchase Program In June 2008, repligen announced that its Board of Directors authorized t...

Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST

... WALTHAM, Mass., Feb. 2 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...or 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results

... WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that...ay be accessed at www.repligen.com . About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST

... WALTHAM, Mass., Nov. 3 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...ed for 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...

Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT

...WALTHAM, Mass., Sept. 17 /PRNewswire-FirstCall/ -- repligen Corporation (Nasdaq: RGEN ) announced today that ...ed for 30 days following the presentation. About repligen Corporation repligen Corporation is a biopharmaceutical company focused...
Repligen in Biological Dictionary

Affymetrix

...t news headlines at MainStreet.com Research AFFYMETRIX INC historical prices, historical volume, splits and dividends. ... Orexigen Therapeutics, repligen and Affymetrix lead small-cap volume in ... Affymetrix to Host Conference Call on July 22, 2009 to Announce Second Quarter 2009 Results ... Af...
Other Tags
(Date:7/29/2014)... HealthDay Reporter TUESDAY, July 29, 2014 ... a single dose of the hormone oxytocin quickly improved their ... Known as the "love hormone," oxytocin has been shown ... between mothers and their children. In this study, it ... brain that has long been associated with the processing of ...
(Date:7/29/2014)... 2014 The Law Offices of Michael Cordova ... Hope, a non-profit organization providing grief camps for kids, teens, ... and suffering our clients experience from the death of a ... an organization like Stepping Stones of Hope, as they provide ... Stones of Hope also includes a monthly support group and ...
(Date:7/29/2014)... transplants receive steady follow-up care, the living donors ... follow-up care more accessible, UC San Francisco and ... launch the first program in the country that ... living kidney donors. , UCSF will provide vouchers ... 4,500 Walgreens pharmacies and Healthcare Clinic at select ...
(Date:7/29/2014)... A team of scientists, led by Western University ... a blood test for Alzheimer’s disease risk that may ... disease interventions, according to an article published July 29, ... study represents one of several pieces that have locked ... years,” Ethell said. , The study, “Women with the ...
(Date:7/29/2014)... Beach, Florida (PRWEB) July 29, 2014 Child ... scholarship for law students this week. The scholarship will help ... abused children and their families. , Steinger, Iscoe and Greene ... abuse, and want tomorrow’s attorneys to do the same. More ... each year according to the nonprofit Childhelp (retrieved ...
Breaking Medicine News(10 mins):Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Caring for donors 2Health News:Caring for donors 3Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Steinger, Iscoe & Greene Offers Child Advocate Scholarship 2
(Date:7/28/2014)... of Medicine have pinpointed a mechanism in part of the ... blood, linking it to both type 1 and type 2 ... of Proceedings of the National Academies of Sciences . ... located in a part of the hypothalamus known as the ... that control glucose levels in the blood," said lead author ...
(Date:7/28/2014)... the top 10 U.S. cities that have seen an ... as frequent road closures, overwhelmed storm drains and compromised ... NOAA technical report. , This nuisance flooding, caused by ... coasts, between 300 and 925 percent since the 1960s. ... Frequency Changes around the United States, also finds Annapolis ...
(Date:7/28/2014)... has identified areas of the Earth that are high ... , Europe is particularly vulnerable, as it has the ... cent, of any continent in ,refugia, areas of ... conditions remain relatively constant during times of great environmental ... mostly in Scandinavia and Scotland. , The biggest ...
Breaking Biology News(10 mins):Glucose 'control switch' in the brain key to both types of diabetes 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2
Other Contents